Research published yesterday in The New England Journal of Medicine describes how an antibody that prevents HIV binding to human immune cells was shown to be able to suppress levels of HIV for up to four months. Kateryna Kon | Shutterstock Human Immunodeficiency virus (HIV) severely damages the immune system, eventually leading to Acquired Immunodeficiency […]Continue Reading ...
The Critical Path Institute (C-Path) and CDISC are pleased to announce the release of a global Therapeutic Area Standard that specifies how to structure commonly collected data and outcome measurements in clinical trials for HIV. The standard, released in the form of User Guide for data managers, statisticians, programmers and study managers, covers the areas […]Continue Reading ...
by Carla K. Johnson This electron microscope image made available by the U.S. National Institutes of Health shows a human T cell, in blue, under attack by HIV, in yellow, the virus that causes AIDS. The virus specifically targets T cells, which play a critical role in the body’s immune response against invaders like bacteria […]Continue Reading ...
Apr 8 2019 Gut microbes from high HIV-risk men who have sex with men drive immune activation in mice and HIV infection in cells, according to a study published April 4 in the open-access journal PLOS Pathogens by Brent Palmer and Catherine Lozupone of the University of Colorado Anschutz, and colleagues. HIV-infected H9 T cell. […]Continue Reading ...
Scanning electromicrograph of an HIV-infected T cell. Credit: NIAID A large team of researchers with members from the U.K., Canada, Uganda and Zimbabwe has found that the common antibiotic cotrimoxazole reduces adverse health events in children with HIV. In their paper published in the journal Science Translational Medicine, the group describes testing the effectiveness of […]Continue Reading ...
Scanning electromicrograph of an HIV-infected T cell. Credit: NIAID And then there were two. A London man infected with HIV has gone into long-term remission after getting a special stem cell transplant that not only treated his cancer, but also sent the virus into remission as well. His recovery, described this week in the journal […]Continue Reading ...
The U.S. Food and Drug Administration today approved Dovato (dolutegravir and lamivudine), as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults with no antiretroviral treatment history and with no known or suspected substitutions associated with resistance to the individual components of Dovato. This is the first FDA-approved […]Continue Reading ...
Women with HIV were once advised against having children for fear that the infection could be passed on to their babies. But medical advancements are not only allowing people with HIV to live longer and fuller lives — but to grow their families, too. Timed vaginal insemination is a safe, effective way to help HIV-affected […]Continue Reading ...
Scanning electromicrograph of an HIV-infected T cell. Credit: NIAID A new study reveals details about the evolutionary contest between HIV and the human immune system that could one day improve treatment. Research led by Shan-Lu Liu of The Ohio State University demonstrates the important role of one protein in allowing HIV to flourish within human […]Continue Reading ...
A person’s sexual behavior could affect their microbiome and immune system, potentially elevating their risk of HIV infection, according to a new study from researchers at the University of Colorado Anschutz Medical Campus. The study was published last week in the journal PLOS Pathogens. The microbiome, a community of microbes in the gut, play a […]Continue Reading ...
Apr 11 2019 The increased survival of white blood cells called neutrophils is associated with alterations in the intestinal microbiome of HIV-infected individuals, according to a study published April 11 in the open-access journal PLOS Pathogens by Nichole Klatt of the University of Miami, and colleagues. Moreover, the findings suggest that Lactobacillus bacteria, which are […]Continue Reading ...
HIV infecting a human cell. Credit: NIH A new way to create proteins that can sneak through HIV’s protective coating may be a step toward understanding the key components needed for developing a vaccine for the virus, according to researchers. Using computational modeling, a team of researchers led by Penn State designed and created proteins […]Continue Reading ...
FDA Approves Dovato (dolutegravir/lamivudine) for HIV-1 Infection LONDON–(BUSINESS WIRE) April 08, 2019 –ViiV Healthcare today announced that the US Food and Drug Administration (FDA) approved Dovato, a complete, once-daily, single-tablet regimen of dolutegravir (DTG) 50 mg and lamivudine (3TC) 300 mg for the treatment of HIV-1 infection in adults with no antiretroviral (ARV) treatment history […]Continue Reading ...
HIV is a tricky virus that causes a unique phenomenon where the virus hides within the immune cells of patients when they are on treatment with the antiretroviral therapy (ART) drugs. When they are off the drugs, the virus comes back. Researchers have now come up with a new drug that can push out the […]Continue Reading ...
Scanning electromicrograph of an HIV-infected T cell. Credit: NIAID In the quest to develop an effective HIV vaccine, researchers have focused attention on identifying and targeting the region of the virus’s outer envelope where a lineage of antibodies are able to dock and neutralize the virus. But true to form with HIV, these broadly neutralizing […]Continue Reading ...
- More TV, Tablets, More Attention Issues at Age 5
- Drug reduces risk of kidney failure in people with diabetes, study finds
- New research identifies novel link between antibiotic resistance and climate change
- Simple intervention can provide lasting protection for teens against junk food marketing
- The protein p38-gamma identified as a new therapeutic target in liver cancer
- Novel system enables researchers to study bacteria within mini-tissues in a dish
- Discovery of oral cancer biomarkers could save thousands of lives
- Geneva Exhibition committee gives gold medals to two medications developed by Kazan
- Scientists aim to minimize or eliminate hair loss during cancer treatment
- WiFi interacts with signaling pathways in the human brain
- Stroke Hospitalizations Down in Black, White Medicare Enrollees
- First common risk genes discovered for autism
- Researchers map auditory sensory system of the mouse brain
- Scientists Bring Pig’s Brain, Dead 4 Hours, Back to ‘Cellular Activity’
- Virtual reality a promising tool for reducing fears and phobia in autism
- New analysis lists out opportunities for U.S. medical schools to advance population health
- More sleep may help teens with ADHD focus and organize
- Breakthrough antibody treatment suppresses HIV without antivirals
- AveXis Data Reinforce Effectiveness of Zolgensma in Treating Spinal Muscular Atrophy (SMA) Type 1
- Is your hand pain arthritis, carpal tunnel or something else?